Glenmark Pharmaceuticals Inc., USA launches Travoprost Ophthalmic Solution USP, 0.004%
Glenmark Pharmaceuticals Inc., USA (Glenmark) is pleased to announce the launch of Travoprost Ophthalmic Solution USP, 0.004% (Ionic Buffered Solution). Glenmark's Travoprost Ophthalmic Solution USP, 0.004% is bioequivalent and therapeutically …